Brigham Hamlin

Brigham Hamlin serves as the Chief Commercial Officer at Credo since June 2024, following a robust tenure at Vim as Chief Revenue Officer and VP of Provider Growth and Success from April 2019 to June 2024, focusing on digital infrastructure for healthcare performance. Prior experience includes serving as National Director of Sales, Strategic, and Regional Sales Director at Counsyl from January 2014 to January 2018, and as Regional Sales Manager and Manager of US Commercial Operations Field Sales Training at Beckman Coulter from January 2009 to January 2013. Brigham holds an MBA in Strategy from NYU Stern School of Business and a BS in Biochemistry and Cell Biology from UC San Diego.